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Summary 
CD45 is a protein tyrosine phosphatase involved in T  and B cell signaling.  While peripheral 
T cells switch CD45 isoforms upon activation, events leading to exon switching during T cell 
development in the thymus have not been determined. The expression of high molecular weight 
isoforms of CD45 was examined on thymocytes from nontransgenic and T cell receptor (TCR) 
transgenic  mice.  All  thymocytes from nontransgenic  mice were CD45RB*  as  assessed by 
staining with MB23G2, an anti-CD45RB-specific monoclonal antibody. Interestingly, there was 
a small population (1-3%) of thymocytes that displayed a higher intensity of staining with MB23G2, 
CD45RBh~g  h.  CD45RBhis h thymocytes were found in all  subsets defined by CD4  and CD8 
expression and were also present within the TCR-odBhis  h population.  To analyze whether or 
not CD45 expression correlated with thymic selection events,  expression of CD45tLB high and 
a second isoform, CD45RA,  was examined on thymocytes from H-Y and 2C TCR transgenic 
mice and found to correlate with positive and negative selection events but did not occur in 
nonselecting backgrounds. CD45RA and CD45RBhlg h upregulation was also not observed in 
transgenic mice backcrossed into CD8-deficient mice, a scenario in which there is no positive 
selection of transgene-expressing  thymocytes. These data suggest that modulation of CD45 isoform 
expression may be involved in thymic selection events. 
C 
D45 is a glycosylated transmembrane protein tyrosine 
phosphatase expressed on all hemopoietic cells except 
erythrocytes and platelets (reviewed in reference 1). Multiple 
isoforms of CD45 are generated through differential splicing 
of extracellular domain exons 4, 5, 6, and 7 (1, 2). The low 
molecular weight isoform of CD45, which lacks exons 4-6, 
is referred to as CD45RO;  however, in the routine system 
there are no antibodies available that detect this isoform (1). 
CD45 isoforms reactive with anti-exon 4-, 5-, and 6-spedfic 
mAbs are referred to as CD45RA, CD45RB, and CD45RC, 
respectively (1). In both human and murine systems, differential 
isoform expression is cell type, differentiation, and activation 
stage specific (1). Cell surface expression of CD45 is required 
for antigen receptor-mediated signaling in T and B cells (3-5). 
A B cell surface molecule, CD22, has been reported to bind 
the  lowest  molecular  weight  isoform  of human  CD45, 
CD45RO (6). However, the functions and ligands for other 
CD45  isoforms still  remain speculative. 
T  cells mature in the thymus, where they are subjected 
to selection processes resulting in the production of a peripheral 
T  cell pool that is restricted to self-MHC molecules but is 
self-tolerant (7).  Studies with TCR V/g-specific antibodies 
and TCR transgenic mice have provided direct evidence for 
tolerance induction by clonal deletion of T cells reactive against 
self-antigens and positive selection of TCR-odB by MHC 
molecules (7-9). The results of these and other studies have 
established  a  model  of  thymic  differentiation  in  which 
TCR/CD3-  CD4-CDS-  (double-negative; DN 1) thymo- 
cyte precursors give rise to immature CD4 +  CD8 + (double- 
positive;  DP)  thymocytes expressing low levels of TCR/ 
CD3. Thymocytes that are positively selected through TCR 
interaction  with  self-MHC  mature  into  CD4§  -  or 
CD4-CD8 + single-positive (SP) cells expressing high levels 
of TCR/CD3  (9,  10). Positive and negative selection most 
likely involves signaling through the TCR. However, the mo- 
lecular events associated with these signals are not well un- 
derstood. 
1Abbreviations used in this  ~tx'r: DN, double negative; DP, double positive; 
SP, single positive. 
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native splicing of the CD45 mRNA, which result in changes 
of CD45 isoform expression at the cell surface (11). How- 
ever, it is not known if signaling through the TCR during 
thymic development can also induce changes in CD45 iso- 
form expression. Thus, CD45 isoform expression was exam- 
ined on thymocytes from nontransgenic and TCR transgenic 
animals.  Previous studies have indicated that the majority of 
immature murine thymocytes express low molecular weight 
CD45 on the call surface (12).  In contrast,  mature CD4 SP 
and CD8 SP thymocytes were shown to express larger mo- 
lecular weight CD45 glycoproteins, suggesting that there is 
a molecular switch in regulation of CD45 protein expression 
upon maturation  of thymocytes to the SP lineage (12).  We 
present  evidence that  the majority  of thymocytes are also 
CD45RB + when stained with MB23G2, an anti-CD45RB- 
specifc mAb (13).  Two populations of CD45RB + thymo- 
cytes were observed,  CD45RB  t~  and  a  small population 
(1-3%) with CD45RBhg h expression. CD45RBhig  h thymo- 
cytes were present in all four subsets defined by CD4 and 
CD8 expression and in a population of TCR-~/~ h~gh thymo- 
cytes. Expression  of CD45RB  high and CD45RA  on TCR 
transgene-positive thymocytes from two different TCR trans- 
genie  mouse  models  was also investigated.  Expression  of 
CD45RBh'g h and  CD45RA  on transgene-positive  thymo- 
cytes was found to correlate with selection events. These results 
suggest that  modulation of CD45 isoform expression may 
be involved in  thymic selection events. 
Materials and Methods 
Mice.  6-wk-old  female BALB/c, B10.BR., C57BL/6, and DBA/2 
mice were obtained from The Jackson Laboratory (Bar Harbor, ME). 
CDS-deficient mice, and H-Y and 2C transgenic lines, have been 
described (9, 14, 15) and were bred in our own facilities. H-Y and 
2C transgenic mice expressing H-2  b (from C57BL/6), H-2  d (from 
BALB/c), and H-2  ~ (from B10.BR) with and without the CD8 
mutation were generated. 
Antibodies and lramunofluorescence.  The following mAb's were 
used: MB23G2 (rat IgG, anti-CD45RB) (13), MB4B4 (rat IgG, 
anti-CD45RB) (16), 14.8 (rat IgG,  anti-CD45RA)  (17), all ob- 
tained from American Type Culture CoUection (RockviUe, MD). 
Biotinylated C363.16A (rat IgG, anti-CD45RB) (18) was obtained 
from Pharmingen  (San Diego, CA). Transgenic TCR expression 
was detected with the following biotinylated mAbs: T3.70, mAb 
specific for the c~ chain of the H-Y-specific  TCK (9); and 1B2, an 
anticlonotypic  mAb specific for the TCR in 2C transgenic mice 
(19) (generous gifts from Drs.  H.-S.  Teh, University  of British 
Columbia, and D. Loh, Washington University, respectively). The 
following  conjugated  antibodies  were  used:  CDS-FITC,  CD8- 
biotin, CD4-PE (Becton Dickinson & Co., Mountain View, CA), 
CD4-FITC, TCR-cff/~-FITC (Pharmingen). For double and triple 
staining, thymocyte suspensions were first incubated with the ap- 
propriate anti-CD45 culture supernatant followed by goat anti-rat 
IgG-PE or goat anti-rat FITC (Southern Biotechnology Associates, 
Birmingham,  AL). Unbound anti-rat Ig sites were blocked with 
1/zg of rat IgG (Sigma Chemical Co., St. Louis, MO). Samples 
were then double or triple stained with the appropriate conjugated 
or biotinylated mAbs. Staining of biotinylated antibodies was de- 
veloped with streptavidin-Texas red (Gibco Laboratories, Grand Is- 
land, NY). As a control for background fluorescence, samples were 
incubated with second-stage goat anti-rat-conjugated  reagents fol- 
lowed by staining with the appropriate anti-TCR mAb. Samples 
were run on a FACScan  |  (Becton Dickinson & Co.). Data from 
viable cells were collected using a live gate by a combination  of 
forward and 90 ~ light  scatter, and 18,000 live gated events were 
collected. CD45RA and CD45RB expression on transgenic thymo- 
cytes was determined in two (H-Y transgenic mice) and three (2C 
transgenic mice) independent experiments. Representative values 
from one experiment  are shown in Figs. 2, 3, and 4. 
Results 
CD45RB  Expression  on  Thymocytes.  Thymocytes from 
C57BL/6,  BALB/c,  and  DBA/2  mice  were  stained  for 
CD45RB expression using the CD45 exon 5-specific mAb 
MB23G2.  All  thymocytes  were  found  to  be  CD45RB + 
(Fig.  1), which is in contrast to previous reports suggesting 
that the majority of immature thymocytes express the lowest 
molecular weight isoform of CD45,  which lacks exons 4, 
5, and 6 (12). Moreover, there was a small population (1-3%) 
of thymocytes that had a higher intensity of CD45RB staining, 
hereafter referred to as CD45RB  high (Fig.  1). Repeated anal- 
ysis yielded consistent results. Triple staining for CD45RB, 
CD4,  and  CD8  expression  on  thymocytes  revealed  that 
CD45R.Bhg h cells  were  present  in  all  thymic  CD4/CD8 
subsets and were enriched in the DN and CD8 SP popula- 
tions  (Table  1).  CD45RBhg  h cells  were also present  on  a 
population  of TCR-o~/~/h* h thymocytes  (Fig.  1).  Similar 
results were obtained with two other CD45RB-specific an- 
tibodies, C363.16A and MB4B4 (16,  18, data not shown). 
The observation that  CD45RB high expression was most 
apparent among TCR.-o~/~  high thymocytes suggested that ex- 
pression of CD45R.B high might be a marker associated with 
the maturation of this subset. TCK transgenic mice provide 
a good model system in which to test this hypothesis since 
the differentiation of transgenic thymocytes can be followed 
with mAbs specific for the transgenic TCK. Therefore,  thymo- 
cytes from two TCK transgenic models, H-Y and 2C, were 
analyzed for CD45RB, CD45RA, and transgene expression 
in positive, neutral (nonsdecting), and negative selection back- 
grounds. 
CD45RA  and CD45RBhia h Expression  on H-Y  ~ansgenic 
Thymocytes.  The H-Y transgenic  TCK is specific for the male 
H-Y antigen in the context of H-2 D b. Positive sdection of 
this transgenic TCK in female H-2  b/b mice is characterized 
by transgene expression,  detected with the mAb T3.70 spedfic 
for the transgenic c~ chain,  on mature CD8 SP thymocytes 
(9). When the transgene is expressed in a nonsdecting back- 
ground, H-2  d/a, thymocytes expressing T3.70 are blocked at 
the DP immature stage of development (9). Although there 
is a small population of thymocytes in H-2  a/d mice that ex- 
press high levels of the transgenic receptor, it has been estab- 
lished  that  these cells  are DN  thymocytes (9).  CD45KA, 
CD45R.Bhg h,  and  T3.70  expression  was  examined  on 
thymocytes from female H-2  b/b and H-2  a/a transgenic mice. 
CD45KA  and  CD45RB hgh  expression was  observed in  a 
population  of T3.70 hgh  ceils  in  H-2  b/b  mice  but  not  in 
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Figure 1.  CD45RB  r 
on thymocytes  from C57BI/6 mice. 
==  Thymocytes from 6-wk-old female 
C57BI/6 mice were double stained 
==  with  anti-CD45RB  (mAb  MB- 
23G2) foLlowed  by goat anti-rat PE 
￿9  and anti-TCR-a//~ HTC. As a con- 
,a=  tml, cells  were stained  with PE-con- 
jugated second stage reagent and 
==  anti-TCR-a//~ FITC. The vertical 
quadrant  marker  was  set  at  the 
TCIL-a//~his  h population. Samples 
'~=,  were run on a FACScan  |  (Becton 
Dickinson  &  Co.),  and  18,000 
events were analyzed. 
T3.70  high thymocytes from  nonselecting H-2  d/d mice  (Fig. 
2).  Triple staining analysis revealed that in H-2  b/b mice the 
CD451LA + T3.70 high thymocytes belonged to the CD8  SP 
(65%),  DP  (5%),  and  DN  (30%)  subsets.  CD45RB high 
T3.70hig  h cdls belonged to the CD8 SP (60%), DP (35%), 
and DN  (5%) subsets. It has been previously demonstrated 
that T3.70  high CD8 SP and T3.70 high DP thymocytes arise 
from positive selection (9,  20).  Therefore,  in H-2  b/b mice, 
the  majority (>70%)  of thymocytes with  CD45RA  and 
CD45RBhig  h  expression  have  been  positively  selected.  It 
should be noted that of the total T3.70  high CD8 SP popula- 
tion,  only 56%  were  CD45RA +  and  52%  CD45R.Bhig  h. 
Sdection of the H-Y TCR  is dependent upon CD8  ex- 
pression since this TCR cannot be selected when the trans- 
gene is backcrossed into mice deficient for CD8 expression 
(CD8 -/-)  (15, 20a). T3.70 + thymocytes from CD8 -/-  fe- 
male H-2  b/b transgenic mice did not  express CD45RA  or 
CD45RBhig  h (data not shown). Therefore, the development 
of T3.70 + thyrnocytes expressing CD45RA or CD45RB~g h 
is dependent upon positive selection of the transgenic TCR 
Table  1.  CD45RB  h~ Expression on  Thymic Subsets Defined 
by CD4 and CD8 Expression 
Percent of CD451LB h~h thymocytes 
Subset  BALB/c  DBA/2 
CD4-CD8-  21.8  _+  5.1  9.1  _+  0.4 
CD4*CD8 §  1.0  +_  1.0  0.7  _+  0.4 
CD4*CD8-  6.4  _+  1.4  4.7  _+  1.0 
CD4-CD8 §  14.0  _+  1.0  20.5  +_  1.0 
Thymocytes from BALB/c and DBA/2 mice were triple stained with 
antibodies  against  CD4,  CD8,  and  CD45RB.  The  percentage  of 
CD45P,.BhI~  h cells in each subset was determined by gating on individu- 
al subsets at the analysis stage. The results are presented as the mean per- 
cent  of CD45R.Bhls  h cells _+  SD  and  represent  the  data  from  two 
individual mice of each mouse strain. 
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Figure 2.  CD45RA and CD45RB expression  on thymocytes  from H-Y 
TCR transgenic mice. Details of staining are described in Materials and 
Methods. Briefly, thymocyte samples were stained with anti-CD451LA 
or anti-CD45RB antibodies followed  by goat anti-rat HTC. Samples  were 
double stained  with a mAb specific  for the transgenic  TCR a chain, T3.70- 
biotin, followed by streptavidin-Tc~ms  red.  Shown are CD45ILA and 
CD45RB vs. T3.70 expression  from selecting H-2  b/b female, nonselecting 
H-2  d/d female, and deleting H-2  b/b male mice. Percentages  of CD45RA + 
and  CD45RBhi8  h thymocytes were obtained after subtraction of goat 
anti-rat background fluorescence  of control samples  as described  in Materials 
and Methods. The position of horizontal quadrant markers  was determined 
on the basis of the staining in a nonselecting thymus, and the goat anti-rat 
control and vertical markers were set at the TCR~  h population. The total 
thymocyte numbers from each of the mice were as follows: female H-2  ha', 
2.7  x  107; female H-2  d/a, 6.3  x  107, and male H-2  b/b, 6.8  x  1@. In 
this analysis,  the female and male H-2  b/b mice were 20-wk-old littermates. 
The female H-2  a/a mouse was 15 wk old. 
1659  Wallace et al. and was not observed in either  of two instances  in which 
there was a lack of positive selection: absence of H-2 D b ex- 
pression  or deficient CD8 expression. 
CD45RA and CD45RB~s  h expression was also examined 
on  T3.70 + thymocytes developing in  the  presence of the 
deleting H-Y antigen in male H-2  b/b transgenic mice.  Nega- 
tive selection in male H-Y mice results in a drastic reduction 
of DP  thymocytes  (9).  The  remaining  T3.70 +  CD8  SP 
thymocytes display a  CD8  ]~  phenotype,  and  it  has  been 
suggested that they represent cells that have escaped negative 
selection  by  downregulating  CD8  surface  expression  (9, 
21).  In  male  transgenic  mice  there  were  populations  of 
CD45KA + T3.70 §  and  CD45RBhig  h T3.70 §  thymocytes 
(Fig.  2).  Triple  staining  revealed  that  CD45RA §  T3.70 § 
thymocytes belonged to the CD8  k'w (16%), DN (78%), and 
the  DP  (6%)  subsets.  Similarly,  CD45RB  hish  T3.70 + 
thymocytes belonged to CD8  ~w (15%), DN (81%), and DP 
(4%) subsets. Since the development of the T3.70 + CD8  l~ 
subset is dependent upon the presence of H-Y/H-2 D b (22), 
CD45RA and CD45RBh~s h expression was occurring on a 
selected  subset  of transgene-positive  thymocytes.  Within 
the T3.70 § CD8  l~  subset, only 50% and 43% of thymo- 
cytes were CD45RA §  and CD45RBhis  h,  respectively. 
Negative selection of the H-Y TCK in male mice is depen- 
dent upon CD8 expression since efficient deletion of trans- 
genic  thymocytes  did  not  occur  in  CD8 -/-  male  trans- 
genic mice (20a).  CD45RA expression was not observed on 
thymocytes from CD8-/-  male mice, however,  CD45RB~ h 
expression on T3.70 + cells was detected (data not shown). 
CD45RA  and  CD45RBhi~  h Expression  on  2C  Transgenic 
Thymocytes.  CD45RA  and  CD45RB ~sh  expression  on 
thymocytes from H-Y mice correlated with selection events. 
To confirm these resuhs,  thymocytes from 2C TCK trans- 
genic  mice were stained for CD45RA,  CD45R.B high, and 
transgene expression.  The 2C transgenic TCR, detected with 
the anticlonotypic mAb 1B2, is alloreactive against H-2 L a 
(19).  Maturation  of 1B2 § T  cells to the CD8 SP compart- 
ment requires the presence of the H-2 K b molecule (23, 24). 
Thymocytes from 2C transgenic mice backcrossed into a non- 
selecting background,  H-2  k/k, are blocked at the immature 
DP stage of development (23).  In nonsdecting mice, 1B2~s  h 
thymocytes belong to the DN compartment (25). As shown 
in Fig. 3,  there are populations of CD45RA +  1B2hig  h and 
CD45RB~s  h 1B2hJs  h thymocytes present in H-2  b/h mice that 
are absent in nonselecting H-2  k/k mice.  Triple staining  re- 
vealed  that  CD45RA +  1B2  high  thymocytes  from  H-2  b/b 
mice  were  CD8  SP  (82%),  DP  (10%),  and  DN  (8%). 
CD45R.Bhig  h 1B2his  h thymocytes were found among CD8 SP 
(70%), DP (16%), and DN (12%) thymocyte subsets. Within 
the 1B2 + CD8 SP mature subset in H-2  b/b mice, only 20% 
of thymocytes expressed CD45RA  or  CD45R.B high. 
CD45RA +  1132  hish thymocytes were also not observed in 
nonselecting  CD8-/-  H-2  b/b 2C  transgenic  mice (Fig.  4; 
20a).  Therefore,  the  appearance  of transgene-positive  thy- 
mocytes in  2C  transgenic  mice expressing  CD45RA  and 
CD45R.B high  was  dependent  upon  sdection  since  these 
populations were not observed when positive selection did 
not occur due to the absence of H-2 K b or CD8 expression. 
In Fig.  3, top left, there is also a population of CD45RA § 
1B2-  thymocytes (1.0%)  with  higher  intensity CD45RA 
expression than CD45KA + 1B2~s  h thymocytes. These cells 
were identified as B cells by their IgM +, Thy-1-, and TCR- 
or//3-  surface phenotype (data not  shown). 
Negative selection of the 2C TCR occurs in the presence 
of H-2 L d molecules and is characterized by deletion of DP 
thymocytes  (23).  As  shown  in  Fig.  3,  CD45RA  and 
CD45KBhis  h expression  are upregulated  on  1B2 +  thymo- 
cytes  in  2C  H-2  d/b  mice.  However,  CD45RA +  and 
CD45RBhig  h cells in H-2  b/a mice have a lower 1B2 intensity 
than CD45KA + and CD45RBhig  h cells in positively select- 
ing H-2  b/b mice (Fig.  3).  Triple staining  with  anti-CD45, 
1B2, and either CD4 or CD8 revealed  that these cells were 
DN (99%) and DP (1%). Deletion of 1B2 + cells is not de- 
pendent on CD8 expression since negative selection of this 
TCR  still  occurs  in  CD8-/-  H-2  b/d 2C  transgenic  mice 
(20a).  CD45RA  expression  on  1B2 §  DN  cells  in  H-2  a/b 
H.2b~ T 
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Figure  3.  CD45ILA and CD45RB expression on thymocytes from 2C 
TCR tramgenic mic~ Thymocyte samples were stained with anti-CD45RA 
or anti-CD45RB antibodies followed by goat anti-rat PE. Samples were 
double stained with a biotinylated anticlonotypic  mAb specific for the 2C 
TCR (1.132), followed by streptavidin-T~as  red. Shown are CD45KA and 
CD45RB vs. 1B2 expression from selecting H-2  b/b, nonselecting H-2 ilk, 
and deleting  H-2  d/b mice. Percentages of CD45KA + and CD45RBh~ h 
thymocytes were determined after subtracting the background fluorescence 
from control samples as described in Materials and Methods.  The posi- 
tions of horizontal quadrant  markers were determined on the basis of the 
staining in nonselecting mice and goat anti-rat control staining, and ver- 
tical markers were adjusted to the TCRhis  h population.  Total numbers of 
thymocytes  from each of the mice were as follows: H-2  brb, 1.3  ￿  107; 
H-2  t/k, 4.6  x  107; and H-2  a/b, 1.2  ￿  107. In this analysis, the mice were 
10-15 wk of age. 
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Figure  4.  CD45RA  expression  on  2C  transgenic  thymocytes  in 
CD8 +/+  and  CD8 -/-  mice.  Thymocytes  were  stained  with  anti- 
CD45RA antibodies and 1B2 as described in Fig. 3. Shown is CD45RA 
vs. 1B2 expression  on thymocytes from CD8 +/+  and CD8 -/-  mice in 
H-2  b/b and H-2  d/b haplotypes. Percentages of CD45RA § thymocytes were 
determined as described in Materials and Methods. Quadrant markers were 
set as described in Fig. 3. The mice in this analysis were 11-15 wk of age. 
CD8-/-  transgenic animals was still observed (Fig. 4).  In 
the thymus of H-2  b/a mice there was also a population of 
1B2-  ceils with high-intensity CD45RA  expression that 
were identified  as  B  cells by  their  IgM +  and  Thy-l.2- 
phenotype (Fig. 3; and data not shown). 
Discussion 
CD45R.B expression was examined on thymocytes from 
normal mice. While all thymocytes were CD45tLB +, there 
was a small population (1-3%) with a higher intensity of 
CD45P,.B expression (CD45R.Bhigh). CD45R.B  high thymo- 
cytes, while present in all four thymic subsets defined by CD4 
and CD8 expression, were predominant in the DN and CD8 
SP subsets. Skewing towards the DN and CD8 SP subsets 
of expression of high molecular weight isoforms of CD45 
has also been reported for CD45RA, CD45RC, and CD45P,.B 
(26-28).  Double staining  with CD45P, B  and TCR-od3- 
specific antibodies  revealed a  population  of CD45R.B high 
TCR-ce/3hig  h thymocytes.  CD45RA  antibodies  have also 
been shown to stain a small population of TCR/CD3his  h 
thymocytes (27). However,  in  contrast  to  our  findings, 
CD45RBhig  h staining  was  found on a population of thy- 
mocytes with an intermediate intensity of TCR-od3 expres- 
sion (28). 
Expression of CD45RA and CD45RB isoforms was also 
examined on thymocytes  from H-Y and 2C TCR transgenic 
mice in selecting (H-2b/b), nonselecting (H-2 a/d for H-Y and 
1661  Wallace et al. 
H-2  k/k for 2C), and deleting (H-2  b/b male mice for H-Y and 
H-2  b/d  for  2C)  backgrounds.  It  has  been  proposed  that 
thymocytes expressing high molecular weight isoforms of 
CD45 represent a thymic generative lineage that maintains 
CD45RA expression throughout intrathymic differentiation 
(29).  The observation  that  CD45RA + and  CD45RB high 
TCR + thymocytes were present among the DN, DP,  and 
CD8 SP subsets in both transgenic models in positive selecting 
backgrounds  may support  this  continuous lineage  model 
whereby CD45RA and CD45RB high are expressed during 
thymic development. However, in nonselecting backgrounds 
of the two different transgenic mouse models, DN and DP 
CD45RA + and CD45R.B  hiSh thymocytes expressing  high 
levels of the transgenic TCR were absent from both TCR 
transgenic mice, a finding that is in conflict with this model. 
Our observations are consistent with an alternative model 
in which expression of CD45RA and CD45R.Bhig  h is in- 
duced by thymic maturation events. In both H-Y and 2C TCR 
transgenic models studied here, expression of CD45KA and 
CD45RB high  on  transgene-positive  thymocytes occurred 
only when the ligands for positive or negative selection were 
present.  In the H-2b/b-sdecting haplotype,  CD45RA  and 
CD45RBhig  h expression on T3.70his  h thymocytes from fe- 
male H-Y mice was observed on a subset of TCKhig  h CD8 
SP and DP thymocytes, both of which are positively selected 
populations (9, 20). Similarly, in H-2  b/b 2C transgenic mice, 
1B2his  h thymocytes expressing CD45RA and CD45R.B  high 
belonged to the positively sdected CD8 SP compartment and 
the DP compartment (23). 1B2h~g  h DP thymocytes likely 
represent positively selected calls since they are not found in 
the nonsdecting (H-2 k/k) background of 2C transgenic mice 
(W.  P.  Fung-Leung,  unpublished  observations).  In male 
H-2  b/b H-Y transgenic animals, CD45RA and CD451~Bhis  h 
expression was observed on CD8  l~  T3.70hig  h cells, a subset 
shown to be dependent upon H-Y/H-2 D b for development 
(22).  T3.70hig  h DP thymocytes expressing CD45RA  and 
CD45R.Bhig  h in male H-Y transgenics may represent thymo- 
cytes that have been positively sdected on H-2 D b or nega- 
tively selected by H-Y/H-2 D b. Therefore, the finding that 
CD45RA  and  CD45RB high expression was  occurring on 
thymocytes that have been selected further supports the hy- 
pothesis  that  selection  events  result  in  CD45RA  and 
CD45RB~g  h expression. It is interesting to note that in H-Y 
male mice homozygous for the CD8 mutation, CD45RBhis  h 
expression was observed on T3.70 high thymocytes. Although 
in the absence of CD8 expression, thymocytes expressing this 
TCR are not clonally deleted (20a), they may still upregulate 
CD45RB high expression in the presence of H-Y/H-2 D b. 
Not all mature calls in a normal thymus are positive for 
CD45RA  and  CD45RBhis h expression.  Similarly, not  all 
mature transgenic  TCR +  CD8  SP  thymocytes in  either 
transgenic model are positive for CD45RA and CD45RB~g  h 
expression, although they express identical TCKs. One pos- 
sibility is that CD45RA and CD45RBh~g  h expression could 
be a transient event during development, perhaps occurring 
upon maturation from DP to mature SP thymocytes  popula- 
tions.  The  increase  in  the  number  of  CD45RA +  or 
CD45RB high ceils among transgenic  thymocytes as com- pared with nontransgenic thymocytes may be due to the fact 
that in transgenic mice more thymocytes have been positively 
selected at any given time. This is supported by the observa- 
tion that there are more CD8 SP and DP TCR  high thymo- 
cytes in transgenic as compared with nontransgenic mice (9, 
23,  30). 
CD45RA and CD45RB high expression was also found on 
TCR.  high DN thymocytes in H-2  b/b HoY and 2C transgenic 
mice. The presence of transgenic TCR.  high DN thymocytes 
has been reported in both transgenic models and their devel- 
opment is not dependent upon positive selection (9, 25). The 
observation that an interaction of CD8 with H-2 D b is re- 
quired for positive selection of the H-Y TCR + cells (31) and 
that  CD8  expression is  required for positive  selection of 
both H-Y and 2C TCR-bearing thymocytes (20a) renders it 
unlikely  that  CD45RA +-  and  CD45RBhigh-expressing 
TCPx  high DN thymocytes detected in H-2  b/b transgenic mice 
are the products of positive selection. An alternative hypoth- 
esis is that these cells may be thymic progenitor cells that 
express the transgenic TCR at an early stage,  since in both 
rat and mouse thymic precursor activity can be detected within 
a population of DN thymocytes expressing high molecular 
weight CD45 (32,  33). This is also supported by data that 
in both transgenic models the transgene is expressed very early 
in development on DN thymocytes (25,  34). 
In 2C H-2b/d-ddeting transgenic mice, 1B2 high thymocytes 
expressing CD45RA  and CD45R.B high were found almost 
exclusively within the DN subset. The observation that there 
were more 1B2 + DN thymocytes expressing CD45RA and 
CD45RBhig  h (45 and 5 times more, respectively) in H-2  b/d 
mice as compared with H-2  b/b mice leads us to speculate that 
these TCR + DN thymocytes have had their TCRs engaged 
by  the  deleting  ligand,  H-2  L a.  Since  CD45RA  and 
CD45R.Bhig  h  expression  occurred  on  thymocytes with  a 
lower intensity of TCR expression in H-2  b/d mice as com- 
pared with CD45RA + and CD45RB hish 1B2  hish thymocytes 
from H-2  b/b mice suggests that these ceUs have escaped nega- 
tive selection by downregulating TCR expression. The pos- 
sibility that these are cells that have been positively selected 
is ruled out by the fact that positive selection of this TCR 
requires CD8 expression (20a) and by the observation that 
these cells are present in H-2  d/d mice (V. A. Wallace, unpub- 
lished observations), where the ligand for positive selection 
is absent. 
The differences in CD45RA and CD45R.B high expression 
on thymocytes described in this report may be due to differen- 
tial binding of the exon-specific mAbs as a result of confor- 
mational or glycosylation changes in the CD45  molecules 
during thymic development rather than differences in exon 
usage.  However,  the  epitopes  detected  by  the  CD45 
exon-specific mAbs used in these experiments are not de- 
pendent upon lymphocyte-specific glycosylation since they 
have been shown to stain CD45-transfected fibroblast lines 
and are not disrupted by the presence of other variable exons 
(16, 35; and V. A. Wallace, unpublished observations).  While 
these results do not completely rule out that the antibodies 
recognize a glycosylated epitope, or that glycosylation on other 
exons may affect epitope recognition, the differential staining 
of thymocytes that we observe with these antibodies clearly 
correlates with selection events. 
In conclusion, the data from normal thymocytes and from 
the transgenic mouse models suggest that thymic selection 
events may induce expression of CD45 isoforms containing 
variable exons. However, activation of peripheral T cells ex- 
pressing high molecular weight CD45 isoforms results in exon 
switching to low molecular weight isoforms (11). This differ- 
ence may arise because the molecular events associated with 
peripheral T cell activation may be different from those initi- 
ated during thymic selection. Alternatively, the goal of thymic 
selection is to produce naive T calls expressing high molec- 
ular  weight  CD45  (36).  The  functional  implications  of 
selection-induced upregulation  of CD45  high  molecular 
weight isoforms on thymocyte signaling and development 
need to be determined. 
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